Private company

Annexin Pharmaceuticals

Swedish pharmaceutical company

Annexin Pharmaceuticals is a Swedish privately held biotech company developing new therapeutic approaches for inflammatory cardiovascular diseases. The concept for the therapy is based on the anti-inflammatory properties of Annexin A5, a body own protective protein that acts simultaneously against several key pathogenic mechanisms of cardiovascular diseases.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

Annexin Pharmaceuticals is a Swedish privately held biotech company developing new therapeutic approaches for inflammatory cardiovascular diseases. The concept for the therapy is based on the anti-inflammatory properties of Annexin A5, a body own protective protein that acts simultaneously against several key pathogenic mechanisms of cardiovascular diseases.2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2